[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100355122":3},{"organization":4,"armGroups":7,"interventions":51,"overallOfficials":101,"centralContacts":119,"locations":128,"responsibleParty":528,"collaborators":531,"id":545,"slug":546,"hasResults":547,"nctId":548,"briefTitle":549,"officialTitle":550,"acronym":551,"eligibilityCriteria":552,"healthyVolunteers":547,"sex":553,"minAge":554,"maxAge":69,"enrollmentInfo":555,"targetDuration":69,"studyType":558,"phases":559,"briefSummary":561,"conditions":562,"keywords":565,"overallStatus":131,"whyStopped":69,"lastUpdateSubmitDate":571,"lastUpdatePostDateStruct":572,"startDateStruct":575,"completionDateStruct":577,"leadSponsor":579,"locationsCount":580},{"fullName":5,"class":6},"Karolinska Institutet","OTHER",[8,19,24,29,34,38,41,46],{"label":9,"type":10,"description":11,"interventionNames":12},"Control: Standard Care","ACTIVE_COMPARATOR","Randomization between assignment to the control arm or the biomarker driven arm will be stratified on biomarker signatures, previous treatment, and fraction of ctDNA and will therefore occur after the results from the ctDNA profiling is obtained. Patients in the control arm will receive standard of care following national guidelines.",[13,14,15,16,17,18],"Drug: Enzalutamide Oral Capsule","Drug: Abiraterone Oral Tablet","Drug: Cabazitaxel 60 mg Solution for Injection","Drug: Docetaxel Injectable Solution","Drug: Radium Chloride Ra-223","Drug: Apalutamide",{"label":20,"type":21,"description":22,"interventionNames":23},"Treatment 1 in mHSPC: AR signalling inhibitors (ARSi)","EXPERIMENTAL","Assignments to therapy in the biomarker driven arms will be done on the basis of the biomarker signature using the current information about the efficacy of the various regimens for that signature. Information from previous studies may be incorporated in the randomization at study onset if such reliable data exists. Specifically, patients with an intact androgen receptor (AR) and without TP53 mutations will have increased chance of being randomized to treatment with ARSi.",[13,14,18],{"label":25,"type":21,"description":26,"interventionNames":27},"Treatment 2 in mHSPC: taxane-based chemotherapy in combination with ARSi","Patients with TP53 mutations and TMPRSS2-ERG gene fusions will have an increased chance of being randomised to treatment with chemotherapy plus an ARSi.",[14,16,28],"Drug: Darolutamide",{"label":30,"type":21,"description":31,"interventionNames":32},"Treatment 3 in mHSPC: Poly ADP Ribose Polymerase (PARP) inhibitor","DNA-repair deficient patients will have an increased chance of receiving PARP inhibitors at study onset.",[33],"Drug: Niraparib plus Abiraterone acetate plus Prednisone",{"label":35,"type":21,"description":36,"interventionNames":37},"Treatment 1 in mCRPC: AR signalling inhibitors (ARSi)","Specifically, patients with an intact androgen receptor (AR) and without TP53 mutations will have increased chance of being randomized to treatment with ARSi.",[13,14],{"label":39,"type":21,"description":31,"interventionNames":40},"Treatment 2 in mCRPC: Poly ADP Ribose Polymerase (PARP) inhibitor",[33],{"label":42,"type":21,"description":43,"interventionNames":44},"Treatment 3 in mCRPC: selective AKT Inhibitor","Patients with alterations in the PI3K pathway will have an increased chance of receiving the combination treatment with Capivasertib plus Docetaxel.",[45],"Drug: Capivasertib plus Docetaxel",{"label":47,"type":21,"description":48,"interventionNames":49},"Treatment 4 in mCRPC: Carboplatin","Only patients with DNA-repair deficiency will be treated with Carboplatin as second line treatment in the castration-resistant phase of ProBio.",[50],"Drug: Carboplatin",[52,59,65,70,73,76,81,87,91,96],{"type":53,"name":54,"description":55,"armGroupLabels":56,"otherNames":57},"DRUG","Enzalutamide Oral Capsule","Detailed conditions for the use of the study treatments including dose and dosages are described in accordance with the marketing authorization in the SmPC (Summary of Product Characteristics).",[9,35,20],[58],"Xtandi",{"type":53,"name":60,"description":61,"armGroupLabels":62,"otherNames":63},"Abiraterone Oral Tablet","Detailed conditions for the use of the study treatment including dose and dosages are described in accordance with the marketing authorisation in the SmPC.",[9,35,20,25],[64],"Zytiga",{"type":53,"name":66,"description":67,"armGroupLabels":68,"otherNames":69},"Carboplatin","Carboplatin will be administered every 3rd week with an AUC (area under curve) = 5 with a dose calculated according to the Carboplatin AUC Dose calculation (Calvert formula):Dose (mg) = TargetAUC (mg\u002Fml x min) x \\[GFR ml\u002Fmin + 25\\].",[47],null,{"type":53,"name":71,"description":61,"armGroupLabels":72,"otherNames":69},"Cabazitaxel 60 mg Solution for Injection",[9],{"type":53,"name":74,"description":61,"armGroupLabels":75,"otherNames":69},"Docetaxel Injectable Solution",[9,25],{"type":53,"name":77,"description":61,"armGroupLabels":78,"otherNames":79},"Radium Chloride Ra-223",[9],[80],"Xofigo",{"type":53,"name":82,"description":83,"armGroupLabels":84,"otherNames":85},"Niraparib plus Abiraterone acetate plus Prednisone","Niraparib and Abiraterone acetate will be provided by Janssen and will be provided either as a fixed dose combination or as single agents. Detailed use of the study treatment including dose and dosages are described in the Investigator's brochures and SmPC.",[39,30],[86],"Akeega",{"type":53,"name":88,"description":89,"armGroupLabels":90,"otherNames":69},"Capivasertib plus Docetaxel","Capivasertib is provided by AstraZeneca and will be given in combination with Docetaxel. All subjects will be given up to ten 21-day docetaxel cycles. All subjects will receive Capivasertib, which will be administered as tablets taken twice a day orally, on a 4 days on\u002F3 days off continuous schedule, commencing cycle one, day 2, until disease progression.",[42],{"type":53,"name":92,"description":55,"armGroupLabels":93,"otherNames":94},"Apalutamide",[9,20],[95],"Erleada",{"type":53,"name":97,"description":55,"armGroupLabels":98,"otherNames":99},"Darolutamide",[25],[100],"Nubeqa",[102,105,108,110,113,116],{"name":103,"affiliation":5,"role":104},"Henrik Grönberg, Professor","PRINCIPAL_INVESTIGATOR",{"name":106,"affiliation":5,"role":107},"Martin Eklund, Professor","STUDY_DIRECTOR",{"name":109,"affiliation":5,"role":107},"Johan Lindberg, PhD",{"name":111,"affiliation":112,"role":104},"Piet Ost, Professor","University Hospital Ghent, Belgium",{"name":114,"affiliation":115,"role":104},"Jan Oldenburg, Professor","University Hospital, Akershus",{"name":117,"affiliation":118,"role":104},"Ashkan Mortezavi, MD, PhD","University Hospital, Basel, Switzerland",[120,125],{"name":121,"role":122,"phone":123,"phoneExt":69,"email":124},"Berit Larsson, MSc","CONTACT","+46 8 52482576","berit.larsson@ki.se",{"name":103,"role":122,"phone":126,"phoneExt":69,"email":127},"+46 70 3411356","Henrik.gronberg@ki.se",[129,147,159,172,181,193,206,216,228,240,252,264,276,290,304,311,323,335,352,366,379,392,405,417,430,441,454,467,480,492,505,519],{"facility":130,"status":131,"city":132,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":135,"geoPoint":140,"contacts":141},"OLV Ziekenhuis Aalst","RECRUITING","Aalst","Belgium","BE",{"type":136,"coordinates":137},"Point",[138,139],4.0355,50.93604,{"lat":139,"lon":138},[142,145],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},"Bram De Laere, PhD","bramdlae.DeLaere@ugent.be",{"name":146,"role":104,"phone":69,"phoneExt":69,"email":69},"Peter Schatterman, MD",{"facility":148,"status":131,"city":149,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":150,"geoPoint":154,"contacts":155},"GZA Sint-Augustinus","Antwerp",{"type":136,"coordinates":151},[152,153],4.40026,51.22047,{"lat":153,"lon":152},[156,157],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":158,"role":104,"phone":69,"phoneExt":69,"email":69},"Michiel Strijbos, MD, PhD",{"facility":160,"status":131,"city":161,"state":69,"zip":162,"country":133,"countryCode":134,"cosmosGeoPoint":163,"geoPoint":167,"contacts":168},"AZ Sint-Jan AV","Bruges","B-8000",{"type":136,"coordinates":164},[165,166],3.22424,51.20892,{"lat":166,"lon":165},[169,170],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":171,"role":104,"phone":69,"phoneExt":69,"email":69},"Christophe Ghysel, MD",{"facility":173,"status":131,"city":161,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":174,"geoPoint":176,"contacts":177},"AZ Sint-Lucas",{"type":136,"coordinates":175},[165,166],{"lat":166,"lon":165},[178,179],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":180,"role":104,"phone":69,"phoneExt":69,"email":69},"Daan De Maeseneer",{"facility":182,"status":131,"city":183,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":184,"geoPoint":188,"contacts":189},"Ziekenhuis Oost-Limburg","Genk",{"type":136,"coordinates":185},[186,187],5.50082,50.965,{"lat":187,"lon":186},[190,191],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":192,"role":104,"phone":69,"phoneExt":69,"email":69},"Wendy De Roock, MD",{"facility":194,"status":131,"city":195,"state":69,"zip":196,"country":133,"countryCode":134,"cosmosGeoPoint":197,"geoPoint":201,"contacts":202},"University Hospital Ghent","Ghent","B-9000",{"type":136,"coordinates":198},[199,200],3.71667,51.05,{"lat":200,"lon":199},[203,204],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":205,"role":104,"phone":69,"phoneExt":69,"email":69},"Piet Ost, Prof. dr.",{"facility":207,"status":208,"city":195,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":209,"geoPoint":211,"contacts":212},"AZ Jan Palfijn Ziekenhuis","NOT_YET_RECRUITING",{"type":136,"coordinates":210},[199,200],{"lat":200,"lon":199},[213,214],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":215,"role":104,"phone":69,"phoneExt":69,"email":69},"Caroline Verbaeys, MD, PhD",{"facility":217,"status":131,"city":218,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":219,"geoPoint":223,"contacts":224},"Jessa ziekenhuis","Hasselt",{"type":136,"coordinates":220},[221,222],5.33781,50.93106,{"lat":222,"lon":221},[225,226],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":227,"role":104,"phone":69,"phoneExt":69,"email":69},"Daisy Luyten, MD",{"facility":229,"status":131,"city":230,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":231,"geoPoint":235,"contacts":236},"AZ Groeninge","Kortrijk",{"type":136,"coordinates":232},[233,234],3.26487,50.82803,{"lat":234,"lon":233},[237,238],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":239,"role":104,"phone":69,"phoneExt":69,"email":69},"Siska Van Bruwaene",{"facility":241,"status":131,"city":242,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":243,"geoPoint":247,"contacts":248},"University Hospital Luik","Liège",{"type":136,"coordinates":244},[245,246],5.56749,50.63373,{"lat":246,"lon":245},[249,250],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":251,"role":104,"phone":69,"phoneExt":69,"email":69},"Brieuc Sautois, MD",{"facility":253,"status":131,"city":254,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":255,"geoPoint":259,"contacts":260},"AZ Damiaan","Ostend",{"type":136,"coordinates":256},[257,258],2.927,51.21551,{"lat":258,"lon":257},[261,262],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":263,"role":104,"phone":69,"phoneExt":69,"email":69},"Jochen Darras, MD",{"facility":265,"status":131,"city":266,"state":69,"zip":69,"country":133,"countryCode":134,"cosmosGeoPoint":267,"geoPoint":271,"contacts":272},"VITAZ","Sint-Niklaas",{"type":136,"coordinates":268},[269,270],4.1437,51.16509,{"lat":270,"lon":269},[273,274],{"name":143,"role":122,"phone":69,"phoneExt":69,"email":144},{"name":275,"role":104,"phone":69,"phoneExt":69,"email":69},"Els Everaert, MD, PhD",{"facility":277,"status":208,"city":278,"state":69,"zip":69,"country":279,"countryCode":280,"cosmosGeoPoint":281,"geoPoint":285,"contacts":286},"Ålesund Sjukehus","Ålesund","Norway","NO",{"type":136,"coordinates":282},[283,284],6.15492,62.47225,{"lat":284,"lon":283},[287,288],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":289,"role":104,"phone":69,"phoneExt":69,"email":69},"Bjorg Y Aksnessaether, MD PhD",{"facility":291,"status":131,"city":292,"state":69,"zip":69,"country":279,"countryCode":280,"cosmosGeoPoint":293,"geoPoint":297,"contacts":298},"Kreftsenter Kristiansand","Kristiansand",{"type":136,"coordinates":294},[295,296],7.9956,58.14671,{"lat":296,"lon":295},[299,302],{"name":300,"role":122,"phone":69,"phoneExt":69,"email":301},"Maria Persson, RN","maria.persson.3@ki.se",{"name":303,"role":104,"phone":69,"phoneExt":69,"email":69},"Christoph Müller, MD, PhD",{"facility":305,"status":131,"city":306,"state":69,"zip":69,"country":279,"countryCode":280,"cosmosGeoPoint":69,"geoPoint":69,"contacts":307},"Akershus Universitetssykehus","Lørenskog",[308,309],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":69},{"name":310,"role":104,"phone":69,"phoneExt":69,"email":69},"Jan Oldenburg, Prof. dr",{"facility":312,"status":131,"city":313,"state":69,"zip":69,"country":279,"countryCode":280,"cosmosGeoPoint":314,"geoPoint":318,"contacts":319},"Stavanger Universitetssjukehus","Stavanger",{"type":136,"coordinates":315},[316,317],5.73332,58.97005,{"lat":317,"lon":316},[320,321],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":69},{"name":322,"role":104,"phone":69,"phoneExt":69,"email":69},"Maria N Vigmostad, MD, PhD",{"facility":324,"status":208,"city":325,"state":69,"zip":69,"country":279,"countryCode":280,"cosmosGeoPoint":326,"geoPoint":330,"contacts":331},"Universitetssykehuset Nord-Norge Tromsö","Tromsø",{"type":136,"coordinates":327},[328,329],18.95508,69.6489,{"lat":329,"lon":328},[332,333],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":334,"role":104,"phone":69,"phoneExt":69,"email":69},"Hege S Haugnes, Prof, dr",{"facility":336,"status":131,"city":337,"state":338,"zip":339,"country":340,"countryCode":341,"cosmosGeoPoint":342,"geoPoint":346,"contacts":347},"Falu lasarett","Falun","Region Dalarna","79182","Sweden","SE",{"type":136,"coordinates":343},[344,345],15.62597,60.60357,{"lat":345,"lon":344},[348,349,350],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":69},{"name":69,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":351,"role":104,"phone":69,"phoneExt":69,"email":69},"Ingrida Verbiéne, MD, PhD",{"facility":353,"status":131,"city":354,"state":69,"zip":69,"country":340,"countryCode":341,"cosmosGeoPoint":355,"geoPoint":359,"contacts":360},"Södra Alvsborgs sjukhus","Borås",{"type":136,"coordinates":356},[357,358],12.9401,57.72101,{"lat":358,"lon":357},[361,364],{"name":362,"role":122,"phone":69,"phoneExt":69,"email":363},"Susanne Johansson, B.Sc.","susanne.johansson@ki.se",{"name":365,"role":104,"phone":69,"phoneExt":69,"email":69},"Christine Jaredsson, MD, PhD",{"facility":367,"status":131,"city":368,"state":69,"zip":369,"country":340,"countryCode":341,"cosmosGeoPoint":370,"geoPoint":374,"contacts":375},"Länssjukhuset Ryhov - Onkologiska kliniken","Jönköping","551 11",{"type":136,"coordinates":371},[372,373],14.15618,57.78145,{"lat":373,"lon":372},[376,377],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":378,"role":104,"phone":69,"phoneExt":69,"email":69},"Linn Pettersson, MD, PhD",{"facility":380,"status":131,"city":381,"state":69,"zip":382,"country":340,"countryCode":341,"cosmosGeoPoint":383,"geoPoint":387,"contacts":388},"Länssjukhuset","Kalmar","392 44",{"type":136,"coordinates":384},[385,386],16.36163,56.66157,{"lat":386,"lon":385},[389,390],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":391,"role":104,"phone":69,"phoneExt":69,"email":69},"Mats Andén, MD, PhD",{"facility":393,"status":131,"city":394,"state":69,"zip":395,"country":340,"countryCode":341,"cosmosGeoPoint":396,"geoPoint":400,"contacts":401},"Centralsjukhuset Region Värmland","Karlstad","651 85",{"type":136,"coordinates":397},[398,399],13.50357,59.3793,{"lat":399,"lon":398},[402,403],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":404,"role":104,"phone":69,"phoneExt":69,"email":69},"Johan Sandzen, MD, PhD",{"facility":406,"status":131,"city":407,"state":69,"zip":69,"country":340,"countryCode":341,"cosmosGeoPoint":408,"geoPoint":412,"contacts":413},"Universitetssjukhuset Örebro","Örebro",{"type":136,"coordinates":409},[410,411],15.2066,59.27412,{"lat":411,"lon":410},[414,415],{"name":362,"role":122,"phone":69,"phoneExt":69,"email":363},{"name":416,"role":104,"phone":69,"phoneExt":69,"email":69},"Jenny Kahlmeter Brandell, MD, PhD",{"facility":418,"status":131,"city":419,"state":69,"zip":420,"country":340,"countryCode":341,"cosmosGeoPoint":421,"geoPoint":425,"contacts":426},"Karolinska University Hospital","Stockholm","17176",{"type":136,"coordinates":422},[423,424],18.06871,59.32938,{"lat":424,"lon":423},[427,428],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":429,"role":104,"phone":69,"phoneExt":69,"email":69},"Anders Ullén, MD, PhD",{"facility":431,"status":131,"city":419,"state":69,"zip":69,"country":340,"countryCode":341,"cosmosGeoPoint":432,"geoPoint":434,"contacts":435},"Capio St.Görans Hospital",{"type":136,"coordinates":433},[423,424],{"lat":424,"lon":423},[436,438,439],{"name":103,"role":122,"phone":69,"phoneExt":69,"email":437},"henrik.gronberg@capiostgoran.se",{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":440,"role":104,"phone":69,"phoneExt":69,"email":69},"Marie Hjälm Eriksson, MD PhD",{"facility":442,"status":131,"city":443,"state":69,"zip":444,"country":340,"countryCode":341,"cosmosGeoPoint":445,"geoPoint":449,"contacts":450},"Länssjukhuset Sundsvall Härnösand","Sundsvall","851 86",{"type":136,"coordinates":446},[447,448],17.3063,62.39129,{"lat":448,"lon":447},[451,452],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":453,"role":104,"phone":69,"phoneExt":69,"email":69},"Elin Jänes, MD PhD",{"facility":455,"status":131,"city":456,"state":69,"zip":457,"country":340,"countryCode":341,"cosmosGeoPoint":458,"geoPoint":462,"contacts":463},"Norrlands Universitetssjukhus","Umeå","90185",{"type":136,"coordinates":459},[460,461],20.25972,63.82842,{"lat":461,"lon":460},[464,465],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":466,"role":104,"phone":69,"phoneExt":69,"email":69},"Camilla Thellenberg Karlsson, MD PhD",{"facility":468,"status":131,"city":469,"state":69,"zip":470,"country":340,"countryCode":341,"cosmosGeoPoint":471,"geoPoint":475,"contacts":476},"Akademiska sjukhuset","Uppsala","75185",{"type":136,"coordinates":472},[473,474],17.63889,59.85882,{"lat":474,"lon":473},[477,478],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":479,"role":104,"phone":69,"phoneExt":69,"email":69},"Gunilla Enblad, Professor",{"facility":481,"status":131,"city":482,"state":69,"zip":69,"country":340,"countryCode":341,"cosmosGeoPoint":483,"geoPoint":487,"contacts":488},"Hallands sjukhus Varberg","Varberg",{"type":136,"coordinates":484},[485,486],12.25078,57.10557,{"lat":486,"lon":485},[489,490],{"name":362,"role":122,"phone":69,"phoneExt":69,"email":363},{"name":491,"role":104,"phone":69,"phoneExt":69,"email":69},"Ingela Franck Lissbrant, MD, PhD",{"facility":493,"status":131,"city":494,"state":69,"zip":495,"country":340,"countryCode":341,"cosmosGeoPoint":496,"geoPoint":500,"contacts":501},"Centrallasarettet Onkologkliniken","Vaxjo","351 85",{"type":136,"coordinates":497},[498,499],14.80906,56.87767,{"lat":499,"lon":498},[502,503],{"name":121,"role":122,"phone":69,"phoneExt":69,"email":124},{"name":504,"role":104,"phone":69,"phoneExt":69,"email":69},"Martha Olsson, MD, PhD",{"facility":506,"status":131,"city":507,"state":69,"zip":69,"country":508,"countryCode":509,"cosmosGeoPoint":510,"geoPoint":514,"contacts":515},"St. Claraspital","Basel","Switzerland","CH",{"type":136,"coordinates":511},[512,513],7.57327,47.55839,{"lat":513,"lon":512},[516,517],{"name":300,"role":122,"phone":69,"phoneExt":69,"email":301},{"name":518,"role":104,"phone":69,"phoneExt":69,"email":69},"Arnoud Templeton, MD",{"facility":520,"status":131,"city":507,"state":69,"zip":69,"country":508,"countryCode":509,"cosmosGeoPoint":521,"geoPoint":523,"contacts":524},"Universitätsspital Basel",{"type":136,"coordinates":522},[512,513],{"lat":513,"lon":512},[525,526],{"name":300,"role":122,"phone":69,"phoneExt":69,"email":301},{"name":527,"role":104,"phone":69,"phoneExt":69,"email":69},"Ashkan Mortezavi, MD PhD",{"type":104,"investigatorFullName":529,"investigatorTitle":530,"investigatorAffiliation":5,"oldNameTitle":69,"oldOrganization":69},"Henrik Grönberg","Professor of Cancer Epidemiology",[532,535,537,540,542],{"name":533,"class":534},"The Swedish Research Council","OTHER_GOV",{"name":536,"class":6},"Kom Op Tegen Kanker",{"name":538,"class":539},"Janssen Pharmaceutica N.V., Belgium","INDUSTRY",{"name":541,"class":539},"AstraZeneca",{"name":543,"class":544},"Cancerfonden","UNKNOWN","100355122","phase-3-probio-a-biomarker-driven-study-in-patients-with-metastatic-prostate-cancer-100355122",false,"NCT03903835","ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer","ProBio: An Outcome-adaptive and Randomized Multi-arm Biomarker Driven Study in Patients With Metastatic Prostate Cancer","ProBio","Inclusion Criteria:\n\n* Man with histologically confirmed prostate adenocarcinoma, initiating systemic therapy for metastatic disease, encompassing newly diagnosed (i.e. de novo) hormone sensitive prostate cancer (mHSPC) or first-line castration resistant prostate cancer (mCRPC)\n* Distant metastatic disease documented by positive bone scan or metastatic lesions on CT or MRI\n* Adequate health as assessed by the investigator to receive all available treatments in the trial\n* ECOG\u002FWHO (Eastern Cooperative Oncology Group\u002F World Health Organization) performance score 0-2\n* Adequate organ and bone marrow function\n* Albumin greater than or equal to 28 g\u002FL\n* Able to understand the patient information and sign written informed consent\n\nExclusion Criteria:\n\n* Other malignancies within 5 years except non-melanoma skin cancer\n* Within 6 months of randomization: myocardial infarction, unstable angina, angioplasty, bypass surgery, stroke, TIA (transient ischemic attack), or congestive heart failure NYHA (New York Heart Association) class III or IV\n* Uncontrolled hypertension\n* Uncontrolled hypotension\n* Received systemic therapy (with the exception of standard ADT) prior to study inclusion, for the CRPC indication\n* Any severe acute or chronic medical condition that places the patient at increased risk of serious toxicity or interferes with the interpretation of study results\n* Unable to comply with study procedures\n* Current participation in another clinical trial that will be in conflict with the present study, administration of an investigational therapeutic or invasive surgical procedure within 28 days prior to study enrolment\n* Patients who are unlikely to comply with the protocol\n* Any condition or situation which, in the opinion of the investigator, would put the subject at risk, may confound study results, or interfere with the subjects participation in this study.\n* Any medical condition that would make use of the study treatments contraindicated, according to the SmPC, e.g. significant heart or liver disease.","MALE","18 Years",{"count":556,"type":557},750,"ESTIMATED","INTERVENTIONAL",[560],"PHASE3","ProBio is an international, outcome-adaptive, multi-arm, open-label, multiple assignment randomized biomarker driven platform trial in patients with metastatic prostate cancer. Patients will be randomized to control or experimental treatment arms. Patients in the control arm will receive standard of care following national guidelines. Patients in the experimental arm will be randomized to treatments based on a biomarker signature inferred from diagnostic tissue or liquid biopsy profiling. The predefined biomarker signatures are tumor properties or mutations in genes\u002Fpathways with previously demonstrated clinical validity (e.g. prognostic value or association with treatment response). The biomarker signatures are identified using a hybridisation capture gene panel specifically designed for prostate cancer.",[563,564],"Metastatic Castration-resistant Prostate Cancer (mCRPC)","Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)",[566,567,568,569,570],"mCRPC","mHSPC","cfDNA","Genomics","Liquid Biopsy","2025-04-07",{"date":573,"type":574},"2025-04-09","ACTUAL",{"date":576,"type":574},"2019-02-01",{"date":578,"type":557},"2026-12",{"name":5,"class":6},32]